Vesicular monoamine transporters (VMAT) catalyze transport of serotonin, dopamine, epinephrine, and norepinephrine into subcellular storage organelles in a variety of cells. Accumulation of the neurotransmitter depends on the proton electrochemical gradient (⌬ H؉ ) across the organelle membrane and involves VMAT-mediated exchange of two lumenal protons with one cytoplasmic amine. Mutagenic analysis of the role of two conserved Asp residues located in transmembrane segments X and XI of rat VMAT type I reveals an important role of these two residues in catalysis. Accumulation of the neurotransmitter depends on the proton electrochemical gradient generated by the vesicular H ϩ -ATPase and involves the VMAT-mediated exchange of two lumenal protons with one cytoplasmic amine (1-5).
H]serotonin transport with modified properties. Whereas the mutated protein binds [ 3 H]reserpine to normal levels and the pH optimum of this reaction is only slightly affected, the optimum pH for transport activity shifted to the acid side and became very sharp; in addition the sensitivity to the inhibitor tetrabenazine increased significantly in this mutated protein. The results point to the need of a carboxyl moiety in position 404. A slight change in its relative location or in the environment around it has a significant effect on the pK of group(s) involved in steps after ligand recognition and coupling to the first H ؉ .
Classical neurotransmitters are stored in synaptic vesicles and storage organelles of secretory cells. Transport of the monoamines serotonin, dopamine, norepinephrine, epinephrine, and histamine into storage organelles in a variety of cells is catalyzed by vesicular monoamine transporters (VMATs). 1 Accumulation of the neurotransmitter depends on the proton electrochemical gradient generated by the vesicular H ϩ -ATPase and involves the VMAT-mediated exchange of two lumenal protons with one cytoplasmic amine (1) (2) (3) (4) (5) .
A model of the mechanism of action of VMAT has been proposed based on a large body of biochemical data. In this model, the first step in the cycle is translocation of a single H ϩ that generates the binding form of the transporter (6). The energy invested in the transporter by H ϩ flux is released by ligand binding and is converted into vectorial movement of a substrate molecule across the membrane or directly into binding energy as measured with the high affinity ligand [ 3 H]reserpine. In the case of a substrate, a second conformational change results in the ligand binding site being exposed to the vesicle interior, where the substrate can dissociate. The second H ϩ in the cycle may be required to facilitate the conformational change or to allow for release of the positively charged substrate from the protein (6) . Binding occurs also in the absence of a proton electrochemical gradient (⌬ Hϩ ) but many times slower (7, 8) .
A clue for the molecular basis of some of these processes was obtained using diethyl pyrocarbonate (DEPC), a reagent relatively specific for His residues (9, 10) . The inhibition by DEPC was specific for His groups because transport could be restored by hydroxylamine (9) . DEPC inhibited transport, although it had no effect on binding of reserpine, indicating that the inhibition of transport was not due to a direct interaction with either of the known binding sites. Interestingly, however, the acceleration of reserpine binding by ⌬ Hϩ was inhibited (9) . The results suggested that either proton transport or a conformational change induced by proton transport was inhibited by DEPC. Practically identical results were obtained with phenylglyoxal, a reagent specific for Arg residues.
Cloning of VMAT (11, 12) made it feasible to try to identify the residue(s) modified by DEPC. Only one His (His-419) is conserved in the VMATs from different species and in the two subtypes (5) . Replacement of His-419 with either Cys (H419C) 2 or Arg (H419R) completely abolished transport as measured in permeabilized CV1 cells transiently transformed with plasmids coding for the mutant proteins. Reserpine binding to the mutant proteins in the absence of ⌬ Hϩ was at levels comparable with those detected in the wild type. However, ⌬ Hϩ did not accelerate reserpine binding to either H419R or H419C proteins. These results suggested that His-419 is associated with H ϩ translocation or in conformational changes occurring after substrate binding (13) .
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cationic amino group of the ligand in ␤-adrenergic receptors (14, 15) and in the plasma membrane dopamine transporter (16, 17) . Four Asp residues are fully conserved in putative transmembrane segments I, VI, X, and XI of the various vesicular neurotransmitter transporters (5) . In addition, biochemical evidence was available that N,NЈ-dicyclohexylcarbodiimide (DCC) inhibits VMAT mediated transport (18 -20) . DCC reacts with a carboxyl residue whose availability is influenced by the occupancy of the TBZ binding site (19) . Reaction with the above carboxyl residue inhibits not only overall transport activity but also TBZ and reserpine binding. As with all chemical modifiers, indirect effects such as steric hindrance by the DCC moiety or indirect effect on the structure of the protein cannot be ruled out at present. Mutagenesis studies of the roles of these Asp residues on VMATs should elucidate this point. Edwards and collaborators have replaced in rVMAT2 Asp-33 (equivalent to Asp-34 in rVMAT1) with Glu and Asn (21 (21) .
Two other conserved Asp residues (Asp-404 and Asp-431) are located in putative transmembrane segments nearby His-419 (transmembrane segments X and XI). In this work we present the results of mutagenesis studies of these two residues. Replacement of Asp-431 to either Glu or Ser abolishes transport activity while having no effect on either reserpine binding or its acceleration due to transport of the first H ϩ in the cycle. The results suggest that Asp-431 plays a role in one of the last steps in the transport catalytic cycle and even a small shift in the location of the carboxyl moiety (D404E) is not tolerated. Replacement of Asp-404 with Glu, on the other hand, shows a very interesting difference: the pH optimum of the transport reaction changes quite dramatically; it shifts about 1 pH unit to the acid side and becomes much narrower. In addition, the mutant protein D404E displays a higher sensitivity to TBZ than the wild type rVMAT1. These findings suggest that the small shift in position of the carboxyl at position 404 obtained by replacement of Asp with Glu modifies the pK of a group (maybe Asp-404 itself), which is involved in transport, possibly H ϩ translocation itself. This change brings also about, either directly or not, a change in the affinity to TBZ. The possible direct involvement of Asp-404 is supported by the fact that replacements in this position with either Ser or Cys inhibit all the VMAT-mediated reactions.
MATERIALS AND METHODS

Growth of Cells, Transfections, and Transport Assays-
The protocol for functional expression of rat VMAT1 was essentially as described by Erickson et al. (12) . CV1 cells grown in 24-well collagen-treated plates were infected with recombinant vaccinia virus encoding bacteriophage T7 DNA polymerase (22) , and after 30 min they were transfected with 1.25 g of plasmid DNA coding for wild type or mutant rVMAT1, using 3.75 g of transfection reagent per well (DOTAP-Boehringer). After 18 -20 h cells were rinsed with uptake buffer containing 110 mM potassium tartrate, 5 mM glucose, 0.2% bovine serum albumin, 5 mM MgCl 2 , 1 mM ascorbic acid, 10 M pargyline, and 20 mM K-Hepes at pH 7.4. Cells were permeabilized for 10 min at 37°C in uptake buffer containing 10 M digitonin. The medium was removed and replaced with fresh buffer without digitonin containing 5 mM NaATP and the corresponding tracers and/or inhibitors as indicated for the specific experiments. At given time periods the reaction buffer was aspirated and discarded, and the cells were washed with ice-cold uptake buffer containing 5 mM MgSO 4 and no tracers. The cells were then collected with 1% SDS, and radioactivity was assessed by liquid scintillation. All data presented are mean values of triplicates. All experiments were repeated at least three times. For each experiment at least one repetition was done with different batches of DNA and CV1 cells. Cells were collected with a rubber policeman, centrifuged, and resuspended in lysis buffer that contains 0.15 M NaCl, 10 mM K-Hepes, pH 8.5, 5 mM MgCl 2 , 5 mM NaEGTA, and 1 g/ml leupeptin. After an additional centrifugation, cells were resuspended in above buffer (200 l/10 7 cells) and sonicated in a bath sonicator for 90 s. Unbroken cells were discarded (3500 ϫ g, 2 min), and the lysate was used to assay binding essentially as described previously (6) . The lysate (containing 250 -500 g of protein) was diluted in a solution containing 320 mM sucrose, 10 mM K-Hepes, pH 8.5, 4 mM KCl, 5 mM ATP, and 5 mM MgSO 4 . [
3 H]Reserpine (20 Ci/mmol) was added to 3 nM or as indicated in the text, and the mixture was incubated at 32°C. After incubation for the time indicated, a 200-l sample of the suspension was applied to a 3-ml column of Sephadex LH-20 (prepacked in a disposable syringe by centrifugation for 20 s in a clinical centrifuge) and centrifuged for 1 min, and the effluent was assayed for radioactivity. The assays were performed in duplicate, and parallel reaction mixtures, containing 5 M reserpine were used to substract nonspecific binding, which was typically less than 10% of the binding to membranes from VMAT-expressing cells. All data presented are mean values of duplicates. All experiments were repeated at least three times. For each experiment at least one repetition was done with different batches of DNA and CV1 cells.
Plasmids-For transient functional expression rVMAT1 was subcloned in the high expression vector pTM1 as described before (13, 23) .
Mutagenesis-Mutants were obtained by polymerase chain reaction mutagenesis using the overlap extension procedure as described previously (13) . For each mutation a set of two overlapping oligonucleotide primers containing the desired codon changes were constructed (Table  I ). In each case the mutagenized fragment was sequenced to verify the mutation and to ensure no other mutations occurred during the amplification process. Sequencing was conducted with the Sequenase kit (version 2.0, U. S. Biochemical Corp.).
RESULTS
Asp-431 and Asp-404 residues are charged residues located in the middle of two putative transmembrane segments in rVMAT1, and they are fully conserved in all the vesicular neurotransmitter transporters sequences available (5 
antisense ATCAGAGAGGAACTCACCATTCCTATGGC
and Fig. 1 ). In order to gain insight into the role of these two conserved Asp in energy coupling and substrate binding, they were mutagenized into either Glu, Cys, or Ser residues, and activity of the mutated protein was assayed. (Fig. 2) . Transport is completely inhibited in the presence of 10 M of the proton ionophore carbonyl cyanide m-chlorophenyl hydrazone as expected from the well known properties of VMAT and by 1 M reserpine, which is a potent competitive inhibitor of monoamine transport (data not shown). Cells transformed with either of the other constructs show practically no measurable activity above the background levels as measured in mock transformed cells.
Replacement of Asp-431 with Either Glu, Cys, or Ser Completely Abolishes Transport Catalyzed by rVMAT1-When
To assess whether the mutants are able to catalyze partial reactions of the transport cycle, [ (Fig. 3) . A time-dependent increase is observed also with membranes from mutants D431S and D431E but not with D431C. (6 -8) . Therefore, addition of uncouplers such as carbonyl cyanide m-chlorophenyl hydrazone reduce the binding rates significantly. The results described in Table II show that the binding to the wild type protein and to D431E and D431S was inhibited by carbonyl cyanide m-chlorophenyl hydrazone to very similar levels. To assess the levels of expression of the various mutants, 
Asp-404 and Asp-431 of rVMAT1
lysates of the cells transformed with the various constructs were tested by Western blotting with an antibody raised against a peptide whose sequence was derived from C-terminal sequences of rVMAT1 (24) . The results shown in Fig. 4 demonstrate that the antibody recognizes rVMAT1 synthesized in CV1 cells as a protein with an apparent molecular mass of 55 kDa with smaller amounts of a 95-kDa protein. This pattern is very similar to what is observed in Chinese hamster ovary and COS cells (21, 24) and previously observed also in CV1 cells (13) . No immunoreactive species is detected in lysates prepared from mock transformed CV1 cells (virus alone or together with pTM1). The mutant proteins D431E and D431S are expressed to levels very similar to those of the wild type. Surprisingly, mutant D431C is not present at detectable levels (Fig. 4) . We have not tested whether the effect on the levels of D431C is due to an effect on its expression or on its stability. It is noteworthy that although two replacements (D431E and D431S) have practically no effect on expression levels, cysteine, which is isosteric to serine, causes such a dramatic effect.
The results demonstrate that modifications in position 431 have no effect on either [ 3 H]reserpine binding to rVMAT1 or on the coupling to ⌬ Hϩ at this step of the cycle, which is thought to involve transport of the first H ϩ . (Fig. 5B) ; whereas D404S and 
Replacement of Asp-404 with Either Cys or Ser but Not with Glu Completely Abolishes Transport Catalyzed by rVMAT1-
FIG. 4. Western blots of membrane preparations from CV1 cells transfected with various plasmids.
Lysates were prepared as described under "Materials and Methods," separated by SDS-polyacrylamide gel electrophoresis and blotted with anti-C terminus rVMAT1 (24) . In the two lanes on the sides of both blots, colored molecular weight markers are visible. Virus alone indicates a lysate prepared from CV1 cells infected with virus but not transfected with plasmids; pTM1 indicates mock transformations with a plasmid with no insert. In all other cases the letters indicate the residue with which the appropriate Asp has been replaced. The blots were performed three times with practically identical results. D404C proteins do not bind this high affinity ligand to levels above the background, D404E binds to about wild type levels (1.4 and 1.8 pmol/mg protein, respectively). Although the activities of the various mutants differ significantly from one another, the levels of protein detected in Western blots are very similar to those detected in cells transformed with wild type plasmid (Fig. 4) . H]Serotonin transport is more dramatically altered, and the pH optimum is narrowed to a clear optimum at around pH 7.6 and a sharp decline on both sides.
Transport of [
Sensitivity of D404E to TBZ Is Significantly Increased-
Because of the partial activity of the D404E protein, we further characterized its properties. Ligand recognition was estimated by the ability of other substrates to inhibit transport. The results in Table III summarize the results of such an experiment. The addition of an excess of unlabeled substrates serotonin, norepinephrine, and dopamine inhibits [ 3 H]serotonin transport significantly and to levels very similar in cells expressing the wild type protein and mutant D404E. Also, ketanserin inhibits significantly both proteins. However, a significant difference is observed in the ability of TBZ (10 M) to inhibit rVMAT1 and mutant D404E: 31 and 89%, respectively. This difference was further probed by testing the ability of various concentrations of TBZ to inhibit transport, and the results are shown in Fig. 7 . Under the given assay conditions, wild type-mediated transport is inhibited 50% at concentrations of above 20 M, whereas D404E-mediated transport is similarly inhibited at about 5-7 M drug.
DISCUSSION
This work presents a description of mutagenesis studies of the role of two conserved Asp residues (Asp-404 and Asp-431) in putative transmembrane domains of rVMAT1. Both Asp residues seem to be important for activity as hinted from the location of charged residues in putative tramsmembrane domains and their full conservation in all the vesicular neurotransmitter transporters (5). In both Asp-404 and Asp-431, The effect is complex because it is not just a shift but also a sharpening of the optimum as well. We cannot therefore conclude at present whether the effect is due to a change in pK a of a single residue. A tempting speculation is that the small shift of location of the carboxyl moiety in the mutant protein as a result of the replacement of Asp-404 with Glu induces a change in its pK a because of the different interactions with other residues. The pK a of amino acids in the protein is dictated by the complex array of interactions with near neighbors and changes in pK a of carboxyl residues upon shift of their position in proteins have been well documented in several cases (for example in Ref. 27 ).
The involvement of Glu and Asp residues in H ϩ transfer has been well established in proton pumps in which high resolution structural information is available; the light-driven pump bacteriorhodopsin (33) reaction centers from photosynthetic bacteria (34) and the cytochrome C oxidase (35, 36 by the ability of various monoamines to inhibit the binding of the high affinity ligand reserpine to the Asp-431 replacements. Neither is it necessary for the transport of the first H ϩ or its coupling to the conformational changes leading to substrate binding, which are estimated from the ability of ⌬ Hϩ to accelerate reserpine binding. Therefore, the role of Asp-431 must be in steps of the catalytic cycle beyond substrate binding and transport of the first H ϩ . Because of the ability of the carboxyl moiety to interact with H ϩ , we speculate that Asp-431 is directly involved in the transport of the second H ϩ required by VMAT. A similar conclusion can be reached for the role of Asp-404 because of the effect of a replacement with Glu on the pH dependence of the overall transport reaction but not on the first steps. However, in this case, removal of the negative charge (D404S and D404E) results in complete inactivation of all the partial reactions measured.
VMAT1 and VMAT2 are two distinct but highly similar subtypes of VMAT. The two subtypes are coded by genes located in different chromosomes (28) and differ in their tissue and subcellular distribution (29 -31) and in their sensitivity to TBZ (32) . Although TBZ is a potent inhibitor of VMAT2 activity, its effect on VMAT1 is much less pronounced (32) . TBZ apparently binds to a site different from the substrate and reserpine binding site (8) . Surprisingly, modification of a residue in VMAT1 that is conserved in both transporters, Asp-404, causes a change in the mutant's affinity to TBZ. The shift in position of the carboxyl moiety may indirectly induce a change in the conformation of the protein such that now it can recognize TBZ with higher affinity. The effect can also be due, as discussed above for the shift in the pH optimum, to a modification in the environment of the carboxyl moiety at position 404, which may be interacting directly with TBZ. The mode by which DCC inhibits VMAT-mediated transport (18 -20) is interesting in this respect. DCC reacts with a carboxyl residue whose availability is influenced by the occupancy of the TBZ binding site (19) . It will be interesting to determine whether Asp-404 is the DCC-reactive carboxyl in rat VMAT1.
The identification in this work and in a previous one (13) of mutant VMAT proteins defective in catalysis of various steps of the catalytic cycle provide strong support to the model of the mechanism of action of VMAT that has been previously proposed based on a large body of biochemical data (6) . This interaction between a mutagenic analysis and a biochemical one should provide an insight into the mode of action of the protein.
